Processa Pharmaceuticals, Inc. (PCSA) Executive Compensation
Processa Pharmaceuticals, Inc. (PCSA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PCSA
CIK: 1533743
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerAdam Hunter
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| PRE 14A | 2026-10-09 | 2026-10-09 | PRE 14A | 0001140361-26-039268 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-09 | 2026-10-09 | PRE 14A | 0001140361-26-039267 | View SEC Doc Filr Page |
| S-3 | 2026-10-09 | — | S-3 | 0001140361-26-039266 | View SEC Doc Filr Page |
| 8-K/A | 2026-10-05 | 2026-07-23 | 8-K/A | 0001140361-26-038535 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-18 | — | SCHEDULE 13G Filing | 0001213900-26-091285 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038334 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-08 | FORM 4 | 0000897069-26-001602 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-30 | 8-K | 0001493152-26-036032 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | 4 Filing | 0001575202-26-000011 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-28 | 3 Filing | 0001575202-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-23 | 8-K | 0001493152-26-035099 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001560 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001558 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001556 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001554 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001552 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001550 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001548 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-26 | FORM 4 | 0000897069-26-001546 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0000897069-26-001484 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0000897069-26-001482 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0000897069-26-001480 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0000897069-26-001478 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0000897069-26-001476 | View SEC Doc Filr Page |
| 4 | 2026-06-30 | 2026-06-26 | FORM 4 | 0000897069-26-001472 | View SEC Doc Filr Page |